Navigation Links
Reportlinker Adds Stem Cell Therapeutics Markets Report
Date:9/24/2009

NEW YORK, Sept. 24 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue.

Stem Cell Therapeutics Markets

http://www.reportlinker.com/p0116170/Stem-Cell-Therapeutics-Markets.html

Political and business events presage change for stem cell therapeutics, most notably the expected move by President Barack Obama to lift federal funding restrictions on stem-cell research. The U.S. Congress has also indicated a desire to move forward with stem cell research. The momentum in two branches of American government, along with scientific developments and the competition of world markets presages good market conditions for stem cell research.

With their ability to differentiate and become an ongoing source of cells that make up critical tissues and organs, stem cells have potential for new regenerative therapies and as new research tools for drug developers to test emerging therapies on diseased cells.

While companies have found opportunity outside the U.S., President Bush's seven year limitations on embryonic stem cell research in the U.S. has limited the U.S. market. Changes in U.S. policy should open up U.S. markets. For market-watchers in the pharmaceutical industry, the question is what potential they have and where they could take the market. Kalorama Information has tackled that question in Stem Cells Therapeutics Markets. Kalorama analyst Alison Sahoo has built models to determine the best case and most likely case scenarios for therapeutic markets for stem cells in the coming years.

This report breaks down forecasted revenues and procedure volumes for stem cell technologies for these segments in the following disease areas:

  • Cardiovascular disease

  • Lung disease

  • Arthritis

  • Incontinence

  • Osteoporosis

  • Diabetes

  • Cancer

  • Orthopedics

  • Infertility

  • Alzheimer's disease

  • Burns (severe)

  • Lupus

  • Parkinson's disease

  • Liver failure

  • Multiple sclerosis

  • Critical limb ischemia

  • Crohn's disease

  • Sickle cell disease

  • Multiple myeloma

  • NH lymphoma

  • Leukemia

This report is the result of exclusive interviews with executives in the stem cell industry, a review of medical and company literature, government databases and publications. As part of this comprehensive analysis of stem cell markets, the following companies were profiled:

  • Aastrom Biosciences

  • Advanced Cell Technologies

  • Brainstorm Cell Therapeutics

  • Celegene

  • ES Cell International

  • Medistem

  • Neostem

  • Opexa Therapeutics

  • Osiris Therapeutics

  • Plureon

  • Regenetech

  • Revivicor

  • Stem Cell Sciences

  • StemLifeLine

  • ThermoGenesis

  • VetCell Bioscience

CHAPTER ONE: EXECUTIVE SUMMARY

Recent Developments

Introduction

Current Stem Cell Therapies

Developmental Stem Cell Therapies

Issues in Stem Cell Research

Stem Cell Forecasts

Market Forecast

The Promise of Stem Cells in Medical Treatment

Types of Stem Cells

Embryonic Stem Cells

Important Developments in ES Cell Research

Adult Stem Cells

Important Developments

Scope and Methodology

CHAPTER TWO: CURRENT STEM CELL THERAPIES

Cancer

Leukemia

Gene Therapy

Multiple Myeloma

Non-Hodgkin's Lymphoma Noncancerous Diseases

Aplastic Anemia

Immunodeficiency

Lupus

Sickle Cell Disease

Other Conditions

CHAPTER THREE: DEVELOPMENTAL STEM CELL THERAPIES

Alzheimer's Disease

Arthritis

Burns

Cancer

Cardiovascular Conditions

Critical Limb Ischemia

Crohn's Disease

Diabetes

Incontinence

Infertility

Liver Failure

Lung Disease

Multiple Sclerosis

Orthopedics

Osteoporosis

Parkinson's Disease

Sickle Cell Disease

CHAPTER FOUR: STEM CELL MARKET FORECASTS

Best Case

Forecasts By Disease Area

Alzheimer's Disease

Arthritis

Burns

Cancer,

Cardiovascular Conditions

Critical Limb Ischemia

Crohn's Disease

Diabetes,

Incontinence

Infertility,

Liver Failure

Lung Disease

Multiple Sclerosis

Orthopedics

Osteoporosis

Parkinson's Disease

Sickle Cell Disease

Most Likely Case

Forecasts By Disease Area

Alzheimer's Disease

Arthritis

Burns

Cancer,

Cardiovascular Conditions

Critical Limb Ischemia

Crohn's Disease

Diabetes,

Incontinence

Infertility,

Liver Failure

Lung Disease

Multiple Sclerosis

Orthopedics

Osteoporosis

Parkinson's Disease

Sickle Cell Disease

CHAPTER FIVE: COMPANY PROFILES

Aastrom Biosciences

Advanced Cell Technologies

Athersys

Brainstorm Cell Therapeutics

Celegene

ES Cell International

Medistem

MultiCell Technologies, Inc.

Neostem

Nephros Therapeutics, Inc.

Opexa Therapeutics

Osiris Therapeutics

Plureon

Regenetech

Revivicor

Stem Cell Sciences

ThermoGenesis

VetCell Bioscience

LIST OF EXHIBITS

CHAPTER ONE: EXECUTIVE SUMMARY

Table 1-2: Stem Cell Therapeutics Market in $ Millions, 2007-2020

CHAPTER TWO: CURRENT STEM CELL THERAPIES

Table 2-1: Types of Leukemia, 2007

CHAPTER THREE: DEVELOPMENTAL STEM CELL THERAPIES

Table 3-1: Global Disease Populations Addressed by Potential Stem Cell Therapies, 2007

Table 3-2: Estimated and Projected World Cancer Incidence by Selected Types of Cancer, 2007 and 2020

Table 3-3: Estimated and Projected World Cancer Mortality by Selected Types of Cancer, 2007 and 2020

Table 3-4: Types and Features of Urinary Incontinence, 2007

Table 3-5: Types and Causes of Male Infertility, 2007

Table 3-6: Common Diseases of the Lungs, 2007

CHAPTER FOUR: STEM CELL MARKET FORECASTS

Table 4-1: Persons Affected by Key Stem Cell Therapeutic Targets in Millions, 2007

Table 4-2: Best Case: Procedure Volume for Proprietary Stem Cell Therapies by Disease in Millions, 2007 - 2020(Alzheimer's Disease, Arthritis, Burns, Cancer, Cardiovascular Conditions, Critical Limb Ischemia, Crohn's Disease, Diabetes, Incontinence, Infertility, Liver Failure, Lung Disease, Multiple Sclerosis, Orthopedics, Osteoporosis, Parkinson's Disease, Sickle Cell Disease)

Table 4-3: Best Case: Revenues for Proprietary Stem Cell Therapies by Disease in $ Millions, 2007 - 2020(Alzheimer's Disease, Arthritis, Burns, Cancer, Cardiovascular Conditions, Critical Limb Ischemia, Crohn's Disease, Diabetes, Incontinence, Infertility, Liver Failure, Lung Disease, Multiple Sclerosis, Orthopedics, Osteoporosis, Parkinson's Disease, Sickle Cell Disease)

Table 4-4: Most Likely Case: Procedure Volume for Proprietary Stem Cell Therapies by Disease in Millions, 2007 - 2020(Alzheimer's Disease, Arthritis, Burns, Cancer, Cardiovascular Conditions, Critical Limb Ischemia, Crohn's Disease, Diabetes, Incontinence, Infertility, Liver Failure, Lung Disease, Multiple Sclerosis, Orthopedics, Osteoporosis, Parkinson's Disease, Sickle Cell Disease)

Table 4-5: Most Likely Case: Revenues for Proprietary Stem Cell Therapies by Disease in $ Millions, 2007-2020(Alzheimer's Disease, Arthritis, Burns, Cancer, Cardiovascular Conditions, Critical Limb Ischemia, Crohn's Disease, Diabetes, Incontinence, Infertility, Liver Failure, Lung Disease, Multiple Sclerosis, Orthopedics, Osteoporosis, Parkinson's Disease, Sickle Cell Disease)

CHAPTER FIVE: COMPANY PROFILES

Table 5-1: Therapeutic Focus of Selected Stem Cell Therapeutics Companies, 2007

To order this report:

Stem Cell Therapeutics Markets

http://www.reportlinker.com/p0116170/Stem-Cell-Therapeutics-Markets.html

More market research reports here!

Nicolas Bombourg

Reportlinker

Email: nbo@reportlinker.com

US: (805)652-2626

Intl: +1 805-652-2626


'/>"/>
SOURCE Reportlinker
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Reportlinker Adds World Market for Cancer Therapeutics and Biotherapeutics, 3rd. Edition, The Report
2. Reportlinker Adds In Vitro Diagnostics in a Recession: IVD Market Forecasts, Analysis and Success Strategies Report
3. Reportlinker Adds High-Tech Patient Monitoring Systems Markets (Remote and Wireless Systems, Data Processing, EMR Data Transfer) Report
4. Reportlinker Adds Membrane Bioreactors Report
5. Reportlinker Adds Nanoporous Materials Report
6. Reportlinker Adds Small Molecule Kinase Inhibitors Report
7. Reportlinker Adds Nanomedicine Report
8. Reportlinker Adds Proteomics: Technologies and Global Markets Report
9. Reportlinker Adds Synthetic Biology: Emerging Global Markets Report
10. Reportlinker Adds Smart Glass: Technologies and Global Markets Report
11. Cell Therapeutics Added to the NASDAQ OMX Global Biotechnology Index
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... 23, 2016  Blueprint Bio, a company dedicated to ... medical community, has closed its Series A funding round, ... "We have received a commitment from Forentis ... need to meet our current goals," stated Matthew ... runway to complete validation on the current projects in ...
(Date:6/23/2016)... ... June 23, 2016 , ... ClinCapture, ... Pennsylvania Convention Center and will showcase its product’s latest features from June 26 ... presenting a scientific poster on Disrupting Clinical Trials in The Cloud during the ...
(Date:6/23/2016)... SAN FRANCISCO , June 22, 2016  Amgen ... platinum sponsorship of the QB3@953 life sciences ... improve human health. The shared laboratory space at QB3@953 ... startups overcome a key obstacle for many early stage ... As part of the sponsorship, Amgen launched two "Amgen ...
(Date:6/22/2016)... Research and Markets has announced the addition of the "Biomarkers: ... The global biomarkers market has grown ... market is expected to grow at a five-year compound annual growth ... billion in 2015 to $96.6 billion in 2020. ... 2020) are discussed. As well, new products approved in 2013 and ...
Breaking Biology Technology:
(Date:6/22/2016)... June 22, 2016 On Monday, the Department ... industry to share solutions for the Biometric Exit Program. ... and Border Protection (CBP), explains that CBP intends to ... the United States , in order ... defeat imposters. Logo - http://photos.prnewswire.com/prnh/20160622/382209LOGO ...
(Date:6/9/2016)... 2016  Perkotek an innovation leader in attendance control systems is proud to announce ... for employers to make sure the right employees are actually signing in, and to ... ... ... ...
(Date:6/2/2016)...   The Weather Company , an IBM Business (NYSE: ... capability in which consumers will be able to interact with ... via voice or text and receive relevant information about the ... Marketers have long sought an advertising solution that can create ... relevant and valuable; and can scale across millions of interactions ...
Breaking Biology News(10 mins):